Modified-Dose Pembrolizumab and Prognostic Outcomes among Non-Small Cell Lung Cancer Patients: A Chart Review Study
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Alberto Mantovani & Paola Allavena & Antonio Sica & Frances Balkwill, 2008. "Cancer-related inflammation," Nature, Nature, vol. 454(7203), pages 436-444, July.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- M. Wozna & B. Kempisty & H. Piotrowska & J. Dorszewska & D. Bukowska & M. Nowicki, 2012. "The immunological, biochemical and molecular bases of canine senescence and carcinogenesis: a review," Veterinární medicína, Czech Academy of Agricultural Sciences, vol. 57(7), pages 350-359.
- Chern-Horng Lee & Sen-Yung Hsieh & Wen-Hung Huang & I-Kuan Wang & Tzung-Hai Yen, 2019. "Association between Ambient Particulate Matter 2.5 Exposure and Mortality in Patients with Hepatocellular Carcinoma," IJERPH, MDPI, vol. 16(14), pages 1-11, July.
- Dong Wook Jekarl & Seungok Lee & Jung Hyun Kwon & Soon Woo Nam & Myungshin Kim & Yonggoo Kim & Jeong Won Jang, 2019. "Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma," PLOS ONE, Public Library of Science, vol. 14(11), pages 1-14, November.
- Tithi Biswas & Kylie H. Kang & Rohin Gawdi & David Bajor & Mitchell Machtay & Charu Jindal & Jimmy T. Efird, 2020. "Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC)," IJERPH, MDPI, vol. 17(21), pages 1-13, October.
- repec:arp:sjmhsm:2022:p:9-17 is not listed on IDEAS
- Vincent Grote & Matthias Frühwirth & Helmut K. Lackner & Nandu Goswami & Markus Köstenberger & Rudolf Likar & Maximilian Moser, 2021. "Cardiorespiratory Interaction and Autonomic Sleep Quality Improve during Sleep in Beds Made from Pinus cembra (Stone Pine) Solid Wood," IJERPH, MDPI, vol. 18(18), pages 1-20, September.
More about this item
Keywords
non-small cell lung cancer; pembrolizumab; neutrophil-to-lymphocyte ratio; low-dose; prognostic;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:10:p:5999-:d:815950. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.